AHA GUIDELINES Bundle (free trial)

Coronary Artery Revascularization

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1435494

Contents of this Issue

Navigation

Page 40 of 49

41 Beta Blockers and Amiodarone in Patients Undergoing CABG COR LOE Recommendations 2a B-R 1. In patients undergoing CABG, who do not have a contraindication to beta blockers, the administration of beta blockers before surgery can be beneficial to reduce the incidence of postoperative atrial fibrillation. 2a B-R 2. In patients undergoing CABG, preoperative amiodarone is reasonable to reduce the incidence of postoperative atrial fibrillation. 2b B-NR 3. In patients undergoing CABG, who do not have a contraindication to beta blockers, preoperative use of beta blockers may be effective in reducing in-hospital and 30-day mortality rates. 2b B-NR 4. In patients undergoing CABG, the role of preoperative beta blockers for the prevention of acute postoperative myocardial ischemia, stroke, AKI, or ventricular arrhythmia is uncertain. Dual Antiplatelet Therapy in Patients After PCI COR LOE Recommendation 2a A 1. In selected patients undergoing PCI, shorter-duration DAPT (1–3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce the risk of bleeding events. Pharmacotherapy in Patients After Revascularization

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Coronary Artery Revascularization